Saturn V Capital Management LP Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$544.9B
Holdings
20
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (20 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ABVXABIVAX SA | 649,179 | $87.5B | 16.07% | |
| 2 | AMLXAMYLYX PHARMACEUTICALS INC | 4,496,487 | $54.3B | 9.97% | |
| 3 | COGTCOGENT BIOSCIENCES INC | 1,217,064 | $43.2B | 7.93% | |
| 4 | JAZZJAZZ PHARMACEUTICALS PLC | 248,070 | $42.2B | 7.74% | |
| 5 | PCVXVAXCYTE INC | 798,940 | $36.9B | 6.77% | |
| 6 | DYNDYNE THERAPEUTICS INC | 1,788,616 | $35.0B | 6.42% | |
| 7 | PHVSPHARVARIS N V | 1,140,033 | $31.6B | 5.81% | |
| 8 | CELCCELCUITY INC | 317,095 | $31.6B | 5.80% | |
| 9 | ALMSALUMIS INC | 3,135,953 | $30.6B | 5.62% | |
| 10 | IRONDISC MEDICINE INC | 298,429 | $23.7B | 4.35% | |
| 11 | XFORX4 PHARMACEUTICALS INC | 5,800,530 | $23.2B | 4.26% | |
| 12 | MNPRMONOPAR THERAPEUTICS INC | 325,701 | $21.3B | 3.90% | |
| 13 | IVVDINVIVYD INC | 7,735,386 | $19.1B | 3.51% | |
| 14 | OCULOCULAR THERAPEUTIX INC | 1,504,880 | $18.3B | 3.35% | |
| 15 | IMMXIMMIX BIOPHARMA INC | 2,999,169 | $15.7B | 2.88% | |
| 16 | OCSOCULIS HOLDING AG | 516,761 | $10.3B | 1.89% | |
| 17 | IKTINHIBIKASE THERAPEUTICS INC | 3,856,799 | $7.9B | 1.45% | |
| 18 | CNTACENTESSA PHARMACEUTICALS PLC | 282,692 | $7.1B | 1.30% | |
| 19 | OVIDOVID THERAPEUTICS INC | 2,500,000 | $4.1B | 0.75% | |
| 20 | IVAINVENTIVA SA | 283,166 | $1.3B | 0.24% |